BioNTech to Buy CureVac in $1.25B Stock Deal That Would Also End mRNA Patent Dispute
BioNTech, a biotech company best known for its successful development of a messenger RNA Covid-19 vaccine, is acquiring…
Deadly Bird Flu Strain Detected In Nevada Man: 4 Stocks To Watch (CORRECTED) – CureVac (NASDAQ:CVAC), GSK (NYSE:GSK)
Editor’s Note: This article has been updated to reflect that GSK acquired full rights to CureVac’s bird flu…
Bird Flu Raising Red Flags Among Health Officials, CDC Urges Faster Testing – CureVac (NASDAQ:CVAC)
The CDC issued a health advisory Thursday recommending that hospitalized patients who have tested positive for influenza be…